Back to Search
Start Over
Correction to: Measurable residual disease status and FLT3 inhibitor therapy in patients with FLT3-ITD mutated AML following allogeneic hematopoietic cell transplantation
- Source :
- Bone Marrow Transplantation. 57:694-694
- Publication Year :
- 2022
- Publisher :
- Springer Science and Business Media LLC, 2022.
- Subjects :
- Transplantation
Hematology
Subjects
Details
- ISSN :
- 14765365 and 02683369
- Volume :
- 57
- Database :
- OpenAIRE
- Journal :
- Bone Marrow Transplantation
- Accession number :
- edsair.doi...........26f9eb3574586c1eb2728c2cabe1369b
- Full Text :
- https://doi.org/10.1038/s41409-022-01606-9